Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRTX vs MRNA✓SelectedUSD · MRNAVRTX vs MRNA performance historyLatest closeAs of-0.67%11/17
Stock and ETF performance explorer

VRTX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.4%
MRNA return
+168.0%
Excess return
-115.6%
Maximum drawdown
-29.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.7%-3.9%+3.3%-0.5%
7D-2.5%-17.6%+15.1%-1.5%
30D+6.9%-5.1%+12.0%+7.0%
3M+3.6%+220.8%-217.2%-6.7%
6M+22.3%+321.7%-299.4%+5.9%
YTD+17.8%+601.3%-583.4%-4.2%
1Y+23.1%+735.2%-712.1%-2.1%
3Y+52.4%+170.5%-118.1%+27.2%
All+52.4%+168.0%-115.6%+27.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling